Forschungszentrum für Immuntherapie (FZI)
Forschungsschwerpunkt / Johannes Gutenberg-Universität Mainz
Rausch, Johanna; Lopez, Pamela Aranda; Bialojan, Ariane et al.
Combined immunotherapy: CTLA-4 blockade potentiates anti-tumor response induced by transcutaneous immunizationJOURNAL OF DERMATOLOGICAL SCIENCE. Bd. 87. H. 3. 2017 S. 300-306
Ashfaq-Khan, Muhammad; Aslam, Misbah; Qureshi, Muhammad Asif et al.
Combined treatment with Rapamycin and Zoledronic Acid strongly inhibits growth of murine hepatocellular carcinoma via activation of the immune microenvironmentHEPATOLOGY. Bd. 66. 2017 S. 422A-423A
Trsan, Tihana; Vukovic, Kristina; Filipovic, Petra et al.
Cytomegalovirus vector expressing RAE-1 gamma induces enhanced anti-tumor capacity of murine CD8(+) T cellsEUROPEAN JOURNAL OF IMMUNOLOGY. Bd. 47. H. 8. 2017 S. 1354-1367
Witkowski, Marco; Steffens, Daniel; Hassanein, Adel et al.
Dabigatran-related platelet thrombin response during triple anti-thrombotic therapy: A matter of time?THROMBOSIS RESEARCH. Bd. 149. 2017 S. 62-63
Waisman, Ari; Lukas, Dominika; Clausen, Bjoern E. et al.
Dendritic cells as gatekeepers of toleranceSEMINARS IN IMMUNOPATHOLOGY. Bd. 39. H. 2. 2017 S. 153-163
Paterka, Magdalena; Voss, Jan Oliver; Werr, Johannes et al.
Dendritic cells tip the balance towards induction of regulatory T cells upon priming in experimental autoimmune encephalomyelitisJOURNAL OF AUTOIMMUNITY. Bd. 76. 2017 S. 108-114
Michel, C. S.; Teschner, D.; Wagner, E. M. et al.
Diagnostic value of sTREM-1, IL-8, PCT, and CRP in febrile neutropenia after autologous stem cell transplantationANNALS OF HEMATOLOGY. Bd. 96. H. 12. 2017 S. 2095-2101
Li, Rui; Rezk, Ayman; Ghadiri, Mathab et al.
Dimethyl Fumarate Treatment Mediates an Anti-Inflammatory Shift in B Cell Subsets of Patients with Multiple SclerosisJOURNAL OF IMMUNOLOGY. Bd. 198. H. 2. 2017 S. 691-698
Schmitt, Edgar; Bopp, Tobias
Discovery and initial characterization of Th9 cells: the early yearsSEMINARS IN IMMUNOPATHOLOGY. Bd. 39. H. 1. 2017 S. 5-10
Uphaus, Timo; Oberwittler, Christoph; Groppa, Sergiu et al.
Disease reactivation after switching from natalizumab to daclizumabJOURNAL OF NEUROLOGY. Bd. 264. H. 12. 2017 S. 2491-2494